被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| The United States: Public Notification: Lipopastilla + Gold Max contains hidden drug ingredients sibutramine and phenolphthalein (English only) |
| |
The US Food and Drug Administration (FDA) is advising consumers not to purchase or use Lipopastilla + Gold Max, a product promoted and sold for weight loss on various websites and possibly in some retail stores. FDA laboratory analysis confirmed that Lipopastilla + Gold Max contains sibutramine and phenolphthalein.
Sibutramine is a controlled substance that was removed from the market in Oct 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.
Phenolphthalein is a chemical that is not an active ingredient in any approved drug in the United States. Studies have indicated that it may increase the risk of cancer.
Please refer to the following website in FDA for details:
http://www.fda.gov/drugs/medication-health-fraud/public-notification-lipopastilla-gold-max-contains-hidden-drug-ingredients
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Monday, Jul 25, 2022
Issued at HKT 14:00
|
| |
